These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37725576)

  • 21. Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm.
    Behdad A; Allen P; Lu X; Zhou XA; Guitart J; Chen Q; Pro B
    Am J Dermatopathol; 2018 Aug; 40(8):610-613. PubMed ID: 29505472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
    Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Likely to be missed if unsuspected":
    Sharma P; Khaire NS; Sreedharanunni S; Malhotra P; Varma N
    J Cancer Res Ther; 2022; 18(1):316-317. PubMed ID: 35381811
    [No Abstract]   [Full Text] [Related]  

  • 24. Relapsed/Refractory T- Acute Lymphoblastic Leukemia - Current Options and Future Directions.
    Jeha S
    Indian J Pediatr; 2024 Feb; 91(2):168-175. PubMed ID: 37642889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.
    Gorantla SP; Zirlik K; Reiter A; Yu C; Illert AL; Von Bubnoff N; Duyster J
    Leukemia; 2015 Aug; 29(8):1763-70. PubMed ID: 25761934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
    Schraders M; van Reijmersdal SV; Kamping EJ; van Krieken JH; van Kessel AG; Groenen PJ; Hoogerbrugge PM; Kuiper RP
    Cancer Genet Cytogenet; 2009 May; 191(1):27-33. PubMed ID: 19389505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.
    Elling C; Erben P; Walz C; Frickenhaus M; Schemionek M; Stehling M; Serve H; Cross NC; Hochhaus A; Hofmann WK; Berdel WE; Müller-Tidow C; Reiter A; Koschmieder S
    Blood; 2011 Mar; 117(10):2935-43. PubMed ID: 21224473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic ETV6-NTRK3 fusion.
    Zhou K; Gong D; He C; Xiao M; Zhang M; Huang W
    Mol Carcinog; 2023 Jul; 62(7):899-906. PubMed ID: 37036164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
    Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
    Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial.
    Jones RL; Serrano C; von Mehren M; George S; Heinrich MC; Kang YK; Schöffski P; Cassier PA; Mir O; Chawla SP; Eskens FALM; Rutkowski P; Tap WD; Zhou T; Roche M; Bauer S
    Eur J Cancer; 2021 Mar; 145():132-142. PubMed ID: 33465704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
    DeAngelo DJ
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1121-35, vii-viii. PubMed ID: 19825456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous T lymphoblastic lymphoma and myeloid neoplasm with PDGFRA rearrangement.
    Pourabdollah M; Gupta M; Schimmer A; Chang H
    Int J Lab Hematol; 2017 Feb; 39(1):e28-e32. PubMed ID: 28013529
    [No Abstract]   [Full Text] [Related]  

  • 33. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
    Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
    Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
    Zhou J; Papenhausen P; Shao H
    Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphoma.
    Borthakur G; Martinelli G; Raffoux E; Chevallier P; Chromik J; Lithio A; Smith CL; Yuen E; Oakley GJ; Benhadji KA; DeAngelo DJ
    Cancer; 2021 Feb; 127(3):372-380. PubMed ID: 33107983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.
    Heinrich MC; Jones RL; von Mehren M; Schöffski P; Serrano C; Kang YK; Cassier PA; Mir O; Eskens F; Tap WD; Rutkowski P; Chawla SP; Trent J; Tugnait M; Evans EK; Lauz T; Zhou T; Roche M; Wolf BB; Bauer S; George S
    Lancet Oncol; 2020 Jul; 21(7):935-946. PubMed ID: 32615108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel gain-of-function mutation in the extracellular domain of the PDGFRA gene in infant acute lymphoblastic leukemia with t(4;11)(q21;q23).
    Hiwatari M; Ono R; Taki T; Hishiya A; Ishii E; Kitamura T; Hayashi Y; Nosaka T
    Leukemia; 2008 Dec; 22(12):2279-80. PubMed ID: 18548106
    [No Abstract]   [Full Text] [Related]  

  • 40. Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.
    Shah S; Loghavi S; Garcia-Manero G; Khoury JD
    J Hematol Oncol; 2014 Mar; 7():26. PubMed ID: 24669761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.